These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 337157)
1. Phase II clinical trials. Carter SK; Selawry O Natl Cancer Inst Monogr; 1977 Mar; (45):81-92. PubMed ID: 337157 [No Abstract] [Full Text] [Related]
2. [Medical treatment of cancer in the elderly]. Bangerter M; Heinrich B; Brudler O MMW Fortschr Med; 2004 Sep; 146(40):30-2. PubMed ID: 15529665 [TBL] [Abstract][Full Text] [Related]
3. Phase II clinical trial of diaziquone in bronchogenic carcinoma. Chiuten DF; Umsawasdi T; Dhingra HM; Murphy WK; Spitzer G; Carr DT; Bodey GP; Valdivieso M Cancer Treat Rep; 1985; 69(7-8):921-2. PubMed ID: 4016800 [No Abstract] [Full Text] [Related]
4. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial. Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601 [No Abstract] [Full Text] [Related]
5. Chemotherapy of solid tumours. World Health Organ Tech Rep Ser; 1977; (605):1-106. PubMed ID: 407727 [No Abstract] [Full Text] [Related]
6. [Results of synchronizing chemotherapy in bronchogenic carcinoma]. Grassi GG; Pozzi E G Ital Chemioter; 1976; 23(1):55-62. PubMed ID: 801001 [No Abstract] [Full Text] [Related]
7. [Phase II study of a new fluorinated pyrimidine, ethyl (+/-)-t-6-butoxy-5-fluoro-2, 4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278)]. Gan To Kagaku Ryoho; 1982 Oct; 9(10):1821-6. PubMed ID: 7184376 [TBL] [Abstract][Full Text] [Related]
9. Panel report. Interdisciplinary group on clinical trials (biostatistics). Zelen M Cancer Chemother Rep 3; 1973 Mar; 4(2):317-9. PubMed ID: 4580859 [No Abstract] [Full Text] [Related]
10. [Clinical phase II trial of a new antineoplastic drug--glyciphosphoramide]. Sun Y Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Aug; 6(4):273-6. PubMed ID: 6241067 [No Abstract] [Full Text] [Related]
13. [After care of operated bronchogenic carcinoma with an atoxic antineoplastic agent]. Hansen JL Ugeskr Laeger; 1975 Jun; 137(26):1466-9. PubMed ID: 1096394 [No Abstract] [Full Text] [Related]
14. Some preliminary observations during the phase I clinical testing of cis-dichlorodiammineplatinum. II. Fiserová J; Dostálová O; Drobník J; Dohnalová J; Holík F Neoplasma; 1973; 20(2):221-2. PubMed ID: 4707844 [No Abstract] [Full Text] [Related]
15. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group]. Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007 [TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of an innoxious antineoplastic agent: preliminary study of 106 patients treated with or without RSV after pulmonary resection for bronchogenic carcinoma. Hansen JL Cancer Chemother Rep 3; 1973 Mar; 4(2):261-4. PubMed ID: 4729327 [No Abstract] [Full Text] [Related]
18. Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial. Kramer BS; Birch R; Greco A; Prestridge K; Johnson R Cancer Treat Rep; 1986 Aug; 70(8):1031-2. PubMed ID: 3524833 [No Abstract] [Full Text] [Related]
19. Ixabepilone and the narrow path to developing new cytotoxic drugs. Gianni L J Clin Oncol; 2007 Aug; 25(23):3389-91. PubMed ID: 17606970 [No Abstract] [Full Text] [Related]
20. Clinical test methods for antitumor drugs in the U.S.S.R. Garin AM; Lichinitser MR Natl Cancer Inst Monogr; 1977 Mar; (45):227-33. PubMed ID: 337153 [No Abstract] [Full Text] [Related] [Next] [New Search]